Home
Country selector

Our Research & Development

Sort

ATM Targeting

DDR

Gain insights into Merck’s research in the pathways involved in DNA damage response (DDR), including targeting ATM enzymes

10 Min

ATR Targeting

DDR

Gain insights into Merck’s research in the pathways involved in DNA damage response (DDR), including targeting ATR enzymes

10 Min

CEACAM5

ADC

Learn about how Merck is investigating carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) as a target for anticancer therapy

10 Min

MET Targeting

Oncogenic Signaling

Discover how Merck is investigating the potential of targeting MET amplification as an anticancer therapy strategy

10 Min

PD-L1 Targeting

IO

Learn about Merck’s research into immuno-oncology medicines that harness the patient’s immune system to fight cancer, including targeting programmed death-ligand 1 (PD-L1)

10 Min

TIGIT Targeting

IO

Learn about Merck’s research into immuno-oncology medicines that harness the patient’s immune system to fight cancer, including targeting T-cell immunoglobulin and ITIM domain (TIGIT)

10 Min

This website is an international information resource intended only for Healthcare Professionals who are licensed to practice outside the U.S., Canada, and Puerto Rico.

The information on this site is intended for educational purposes.

Connect with us

Find the Healthcare Business of Merck on:

©2024 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved. Registered address: Merck KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany

GL-MULO-00155 | November 2023

Cookie Disclaimer

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide which categories you would like to permit. Please note that depending on the settings you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Policy.

ACCEPT COOKIES
Your settings for the cookies

These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.

In order to continuously improve our website, we anonymously track data for statistical and analytical purposes. With these cookies we can, for example, track the number of visits or the impact of specific pages of our web presence and therefore optimize our content. 

These cookies allow us to provide more comfort for you. For example, previously searched products or services can be reloaded again after revisiting our website and you won’t need to enter all the details again. We can also detect if you need assistance with using our website and therefore offer you direct customer support.

These cookies are used to display personalized content matching your interests. We can display personalized and relevant services to ensure you are always up to date on related offers.

By clicking this link, you are leaving MerckGroupOncology.com. Please, note that this link will take you to a website оn which different Privacy Policy and Conditions may apply. Merck accepts no responsibility for websites not controlled directly by us. Please check Privacy Policy and Conditions of the linked website.

Continue
Go Back

Welcome to Merck Healthcare!

Help us direct you to the right information by selecting one of the following options:

I'm a Healthcare Professional

I'm NOT a Healthcare Professional